Key result
Cardiovascular manifestations were present in 58.3% of patients with rheumatoid arthritis, and these patients had a higher rate of rheumatoid factor positivity compared to those without cardiovascular manifestations.
Why the study?
The increased inflammatory burden in rheumatoid arthritis may lead to atherosclerosis, myocardial infarction, and subsequent mortality, prompting investigation into the frequency of cardiovascular manifestations.
Cross-Sectional (n=322)
No
Over half of patients with rheumatoid arthritis exhibited cardiovascular manifestations, which were significantly associated with higher inflammatory markers and rheumatoid factor positivity, highlighting the need for routine cardiac screening in this population.
Answers are grounded in this paper and cite their sources.
Supports routine cardiovascular screening in rheumatoid arthritis patients with positive rheumatoid factor; leaves open whether targeted.
Introduction Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease. The increased inflammatory burden in RA may result in atherosclerosis, myocardial infarction (MI), and subsequent mortality. In this study, we will determine the frequency of cardiovascular manifestation in RA patients through history, laboratory workup, and echocardiography. Methods This cross-sectional study was conducted in the rheumatology unit of a tertiary care hospital in Pakistan. Three hundred and twenty-two (n=322) participants with a previously confirmed diagnosis of RA were enrolled in this study via consecutive convenient non-probability sampling. Results Cardiovascular manifestations were present in 188 (58.3%) participants. More participants had positive rheumatoid factor (82.9% vs. 32.8%; p-value: < 0.0001) in RA patients with cardiovascular manifestation compared to RA patients without cardiovascular manifestation. Patients with cardiovascular manifestations have a significantly higher C-reactive protein (CRP; 10.21 ± 2.81 mg/L vs. 8.17± 2.01 mg/L; p value: < 0.0001) and erythrocyte sedimentation rate (ESR; 16.2 ± 3.14 mg/L vs. 15.1 ± 2.99 mg/L; p value: 0.0017). Conclusion In this study, patients with a cardiovascular manifestation had a higher frequency of patients with rheumatoid factor, higher mean values of CRP and ESR. The early diagnosis and management of cardiac manifestations would aid in controlling the severity of the disease and the overall mortality.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2021) conducted a cross-sectional in Rheumatoid arthritis (n=322). Cardiovascular manifestations vs. No cardiovascular manifestations was evaluated on Rheumatoid factor positivity (p=< 0.0001). Cardiovascular manifestations were present in 58.3% of patients with rheumatoid arthritis, and these patients had a higher rate of rheumatoid factor positivity compared to those without cardiovascular manifestations.
Synapse has enriched 10 related papers. Consider them for comparative context: